5-amino-1mq 50mg

Description

5-Amino-1MQ is a small-molecule NNMT (Nicotinamide N-methyltransferase) inhibitor that sits at the cutting edge of metabolic pharmacology — a compound that targets fat cell energy regulation at the enzymatic level. NNMT is overexpressed in white adipose tissue and acts as a metabolic brake, consuming SAM (S-adenosylmethionine) to suppress NAD+ biosynthesis and impair mitochondrial function in fat cells. By inhibiting NNMT, 5-Amino-1MQ restores NAD+ levels within adipocytes, activates SIRT1 and AMPK signalling, and drives a shift toward fat oxidation and energy expenditure. Animal studies have demonstrated significant reductions in adipocyte size, body weight, and cholesterol without changes in food intake — the hallmark of a metabolic rate modulator rather than an appetite suppressant. At 50mg, this is the dose range used in emerging human research protocols. Stack with NAD+ precursors (NMN, NR) for synergistic metabolic enhancement. Independently verified at 99%+ purity by Puralytix. Current research protocols typically use 50mg once daily in the morning for metabolic synergy with circadian patterns of NNMT expression. The compound is fat-soluble and benefits from co-ingestion with dietary fat. Stack with NMN or NR to provide the NAD+ precursor substrate that 5-Amino-1MQ’s NNMT inhibition frees from methylation — a pharmacologically rational combination for maximum metabolic enhancement.